Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
about
A Critical Review of Alpha Radionuclide Therapy-How to Deal with Recoiling Daughters?Effect of Surface Functionalization on the Cellular Uptake and Toxicity of Nanozeolite A.Simultaneous Separation of Actinium and Radium Isotopes from a Proton Irradiated Thorium Matrix.Development of separation technology for the removal of radium-223 from decayed thorium-227 in drug formulations. Material screening and method development.Ra-224 Labeling of Calcium Carbonate Microparticles for Internal α-Therapy: Preparation, Stability and Biodistribution in Mice.Targeted and Nontargeted α-Particle Therapies.
P2860
Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
@en
Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
@nl
type
label
Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
@en
Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
@nl
prefLabel
Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
@en
Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
@nl
P2093
P2860
P1476
Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.
@en
P2093
Agata Piotrowska
Alfred Morgenstern
Edyta Leszczuk
Frank Bruchertseifer
P2860
P2888
P356
10.1007/S11051-013-2082-7
P577
2013-10-31T00:00:00Z